InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,929.04
(
2.53%
)
US TECH 100
20,262.80
(
0.20%
)
Dow Jones
43,729.93
(
3.57%
)
Brent Oil
74.13
(
-1.26%
)
Bitcoin
74,894.51
(
-0.99%
)
Post# of 403749
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

georgejjl

Send PM Follow Ignore
Followers 141
Posts 23971
Boards Moderated 0
Alias Born 04/08/2004

georgejjl

Re: georgejjl post# 193831

Wednesday, 08/16/2017 9:55:44 PM

Wednesday, August 16, 2017 9:55:44 PM

Post# of 403749
The 3:1:3 trial design gives sufficient subjects to provide statistically significant results in a double blind placebo controlled randomized trial.

Good luck and GOD bless,

George
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM

Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM

North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM

Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Start posting your company's news
Only $200 per official company press release!